Financial Year |
March 31 2023 |
Monetary Funds |
339,600,738,000.00 |
Held-for-trading Financial Assets |
17,825,000.00 |
Notes Receivable |
7,628,158,000.00 |
Accounts Receivable |
208,372,627,000.00 |
Advances to Suppliers |
40,018,401,000.00 |
Other Receivables |
76,687,630,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
794,675,002,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
56,964,135,000.00 |
Other Current Assets |
128,170,450,000.00 |
Total Current Assets |
1,936,796,271,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
107,648,705,000.00 |
Long-term Equity Investment |
113,380,002,000.00 |
Investment Properties |
151,045,632,000.00 |
Fixed Assetes |
49,541,877,000.00 |
Under-construction Projects |
4,727,590,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
26,621,599,000.00 |
R&D expenses |
-- |
Goodwill |
2,309,753,000.00 |
Long-Term Deferred and Prepaid Expenses |
1,344,525,000.00 |
Deferred Income Tax Assets |
20,985,755,000.00 |
Other Non-Current Assets |
262,304,548,000.00 |
Sub-Total of Non-Current Assets |
777,162,287,000.00 |
Total Assets |
2,713,958,558,000.00 |
Short-Term Loans |
134,807,455,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
11,607,378,000.00 |
Accounts Payable |
557,304,370,000.00 |
Accounts Received In Advance |
788,305,000.00 |
Employee Compensation Payable |
8,070,499,000.00 |
Taxes Payable |
61,677,896,000.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
129,479,748,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
139,816,075,000.00 |
Other Current Liabilities |
82,853,575,000.00 |
Sub-Total of Current Liabilities |
1,466,621,988,000.00 |
Long-term Loans |
408,823,327,000.00 |
Bonds Payable |
107,647,943,000.00 |
Long-Term Accounts Payable |
12,153,501,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
3,861,888,000.00 |
Deferred Income Tax Liabilities |
10,580,953,000.00 |
Other Non-Current Liabilities |
4,733,542,000.00 |
Sub-Total of Non-Current Liabilities |
554,808,666,000.00 |
Total Liabilities |
2,021,430,654,000.00 |
Paid-In Capital(Or Share Stock) |
41,934,433,000.00 |
Capital Surplus |
11,808,020,000.00 |
Surplus Reserve |
14,349,125,000.00 |
LESS:Treasury Stock |
1,880,038,000.00 |
Undistributed Profits |
322,318,896,000.00 |
Minority Stockholder's Interest |
296,771,681,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
395,756,223,000.00 |
Owner's Equity(Stockholder's Equity) |
692,527,904,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,713,958,558,000.00 |